Pan-Canadian Analysis of Practice Patterns in Small Cell Carcinoma of the Cervix: Insights from a Multidisciplinary Survey
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- WHO Classification of Tumours of Female Reproductive Organs; International Agency for Research on Cancer: Lyon, France, 2014.
- Winer, I.; Kim, C.; Gehrig, P. Neuroendocrine tumors of the gynecologic tract update. Gynecol. Oncol. 2021, 162, 210–219. [Google Scholar] [CrossRef] [PubMed]
- Satoh, T.; Takei, Y.; Treilleux, I.; Devouassoux-Shisheboran, M.; Ledermann, J.; Viswanathan, A.N.; Mahner, S.; Provencher, D.M.; Mileshkin, L.; Åvall-Lundqvist, E.; et al. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Small Cell Carcinoma of the Cervix. Int. J. Gynecol. Cancer 2014, 24, S102–S108. [Google Scholar] [CrossRef] [PubMed]
- Salvo, G.; Martin, A.G.; Gonzales, N.R.; Frumovitz, M. Updates and management algorithm for neuroendocrine tumors of the uterine cervix. Int. J. Gynecol. Cancer 2019, 29, 986–995. [Google Scholar] [CrossRef] [PubMed]
- Marth, C.; Landoni, F.; Mahner, S.; McCormack, M.; Gonzalez-Martin, A.; Colombo, N.; on behalf of the ESMO Guidelines Committee. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2017, 28, iv72–iv83. [Google Scholar] [CrossRef]
- Huang, R.; Yu, L.; Zheng, C.; Liang, Q.; Suye, S.; Yang, X.; Yin, H.; Ren, Z.; Shi, L.; Zhang, Z.; et al. Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: A meta-analysis. Sci. Rep. 2020, 10, 14975. [Google Scholar] [CrossRef] [PubMed]
- Castle, P.E.; Pierz, A.; Stoler, M.H. A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix. Gynecol. Oncol. 2018, 148, 422–429. [Google Scholar] [CrossRef] [PubMed]
- Tempfer, C.B.; Tischoff, I.; Dogan, A.; Hilal, Z.; Schultheis, B.; Kern, P.; Rezniczek, G.A. Neuroendocrine carcinoma of the cervix: A systematic review of the literature. BMC Cancer 2018, 18, 530. [Google Scholar] [CrossRef] [PubMed]
- Alberta Innovates. ARECCI Ethics Screening Tool (A pRoject Ethics Community Consensus Initiative); Alberta Innovates: Edmonton, AB, Canada, 2017. [Google Scholar]
- NCCN. National Comprehensive Cancer Network. Guidelines Version 1.2024 Cervical Cancer; NCCN National Comprehensive Cancer Network: Plymouth Meeting, PA, USA, 2024. [Google Scholar]
- Carroll, M.R.; Ramalingam, P.; Salvo, G.; Fujimoto, J.; Soto, L.M.S.; Phoolcharoen, N.; Hillman, R.T.; Cardnell, R.; Byers, L.; Frumovitz, M. Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix. Int. J. Gynecol. Cancer 2020, 30, 1303–1307. [Google Scholar] [CrossRef]
- Wang, R.; Xiao, Y.; Ma, L.; Wu, Z.; Xia, H. Exploring a Better Adjuvant Treatment for Surgically Treated High-Grade Neuroendocrine Carcinoma of the Cervix. Gynecol. Obstet. Invest. 2022, 87, 398–405. [Google Scholar] [CrossRef]
- Boruta, D.M.; O Schorge, J.; A Duska, L.; Crum, C.P.; Castrillon, D.H.; E Sheets, E. Multimodality Therapy in Early-Stage Neuroendocrine Carcinoma of the Uterine Cervix. Gynecol. Oncol. 2001, 81, 82–87. [Google Scholar] [CrossRef]
- Kim, C.; Salvo, G.; Ishikawa, M.; Chen, T.C.; Jhingran, A.; Bhosale, P.; Ramalingam, P.; Frumovitz, M. The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: A meta-analysis. Gynecol. Oncol. 2023, 170, 328–332. [Google Scholar] [CrossRef] [PubMed]
- Chu, T.; Meng, Y.; Wu, P.; Li, Z.; Wen, H.; Ren, F.; Zou, D.; Lu, H.; Wu, L.; Zhou, S.; et al. The prognosis of patients with small cell carcinoma of the cervix: A retrospective study of the SEER database and a Chinese multicentre registry. Lancet Oncol. 2023, 24, 701–708. [Google Scholar] [CrossRef] [PubMed]
- Chen, T.-C.; Huang, H.-J.; Wang, T.-Y.; Yang, L.-Y.; Chen, C.-H.; Cheng, Y.-M.; Liou, W.-H.; Hsu, S.-T.; Wen, K.-C.; Ou, Y.-C.; et al. Primary surgery versus primary radiation therapy for FIGO stages I–II small cell carcinoma of the uterine cervix: A retrospective Taiwanese Gynecologic Oncology Group study. Gynecol. Oncol. 2015, 137, 468–473. [Google Scholar] [CrossRef]
- Margolis, B.; Tergas, A.I.; Chen, L.; Hou, J.Y.; Burke, W.M.; Hu, J.C.; Ananth, C.V.; Neugut, A.I.; Hershman, D.L.; Wright, J.D. Natural history and outcome of neuroendocrine carcinoma of the cervix. Gynecol. Oncol. 2016, 141, 247–254. [Google Scholar] [CrossRef] [PubMed]
- Hou, W.-H.; Schultheiss, T.E.; Wong, J.Y.; Wakabayashi, M.T.; Chen, Y.-J. Surgery Versus Radiation Treatment for High-Grade Neuroendocrine Cancer of Uterine Cervix: A Surveillance Epidemiology and End Results Database Analysis. Int. J. Gynecol. Cancer 2018, 28, 188–193. [Google Scholar] [CrossRef]
- Zivanovic, O.; Leitao, M.; Park, K.; Zhao, H.; Diaz, J.; Konner, J.; Alektiar, K.; Chi, D.; Abu-Rustum, N.; Aghajanian, C. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy. Gynecol. Oncol. 2009, 112, 590–593. [Google Scholar] [CrossRef] [PubMed]
- Robin, T.P.; Amini, A.; Schefter, T.E.; Behbakht, K.; Fisher, C.M. Brachytherapy should not be omitted when treating locally advanced neuroendocrine cervical cancer with definitive chemoradiation therapy. Brachytherapy 2016, 15, 845–850. [Google Scholar] [CrossRef] [PubMed]
- Paz-Ares, L.; Dvorkin, M.; Chen, Y.; Reinmuth, N.; Hotta, K.; Trukhin, D.; Statsenko, G.; Hochmair, M.J.; Özgüroğlu, M.; Ji, J.H.; et al. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): A randomised, controlled, open-label, phase 3 trial. Lancet 2019, 394, 1929–1939. [Google Scholar] [CrossRef] [PubMed]
- Horn, L.; Mansfield, A.S.; Szczęsna, A.; Havel, L.; Krzakowski, M.; Hochmair, M.J.; Huemer, F.; Losonczy, G.; Johnson, M.L.; Nishio, M.; et al. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. N. Engl. J. Med. 2018, 379, 2220–2229. [Google Scholar] [CrossRef]
- Frumovitz, M.; Chisholm, G.B.; Jhingran, A.; Ramalingam, P.; Flores-Legarreta, A.; Bhosale, P.; Gonzales, N.R.; Hillman, R.T.; Salvo, G. Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: A Neuroendocrine Cervical Tumor Registry (NeCTuR) study. Am. J. Obstet. Gynecol. 2023, 228, e1–e445. [Google Scholar] [CrossRef]
- Frumovitz, M.; Westin, S.N.; Salvo, G.; Zarifa, A.; Xu, M.; Yap, T.A.; Rodon, A.J.; Karp, D.D.; Abonofal, A.; Jazaeri, A.A.; et al. Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract. Gynecol. Oncol. 2020, 158, 570–575. [Google Scholar] [CrossRef] [PubMed]
- Frumovitz, M.; Burzawa, J.K.; Byers, L.A.; Lyons, Y.A.; Ramalingam, P.; Coleman, R.L.; Brown, J. Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer. Gynecol. Oncol. 2016, 141, 588–591. [Google Scholar] [CrossRef] [PubMed]
- Cimic, A.; Vranic, S.; Arguello, D.; Contreras, E.; Gatalica, Z.; Swensen, J. Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix. Appl. Immunohistochem. Mol. Morphol. AIMM 2021, 29, 299–304. [Google Scholar] [CrossRef] [PubMed]
- Eskander, R.N.; Elvin, J.; Gay, L.; Ross, J.S.; Miller, V.A.; Kurzrock, R. Unique genomic landscape of high-grade neuroendocrine cervical carcinoma: Implications for rethinking current treatment paradigms. JCO Precis. Oncol. 2020, 4, 972–987. [Google Scholar] [CrossRef] [PubMed]
Institution Characteristics | N | % | |
Province | Ontario | 8 | 24 |
Quebec | 6 | 18 | |
British Columbia | 6 | 18 | |
Alberta | 5 | 15 | |
Manitoba | 3 | 9 | |
Newfoundland | 2 | 6 | |
Nova Scotia | 2 | 6 | |
Saskatchewan | 2 | 6 | |
Academic institution | Yes | 30 | 88 |
No | 4 | 12 | |
Specialties available | Gynecologic oncology | 32 | 94 |
Radiation oncology | 34 | 100 | |
Medical oncology | 33 | 97 | |
Primary specialty that delivers systemic therapy | Gynecologic oncology | 19 | 56 |
Medical oncology | 15 | 44 | |
Radiation oncology | 0 | 0 | |
Number of patients with SCNECC treated annually | 0 | 1 | 3 |
1 to 4 | 30 | 88 | |
5 to 10 | 2 | 6 | |
>10 | 1 | 3 | |
Practitioner Characteristics | N | % | |
Primary specialty of practice | Gynecologic oncology | 17 | 50 |
Medical oncology | 4 | 12 | |
Radiation oncology | 13 | 38 | |
Number of years in practice | ≤5 | 6 | 18 |
6 to 10 | 6 | 18 | |
11 to 15 | 11 | 32 | |
≥16 | 11 | 32 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Fan, K.Y.; Chehade, R.; Wang, A.Y.; Sachdeva, A.; MacKay, H.J.; Taggar, A.S. Pan-Canadian Analysis of Practice Patterns in Small Cell Carcinoma of the Cervix: Insights from a Multidisciplinary Survey. Curr. Oncol. 2024, 31, 2610-2619. https://doi.org/10.3390/curroncol31050196
Fan KY, Chehade R, Wang AY, Sachdeva A, MacKay HJ, Taggar AS. Pan-Canadian Analysis of Practice Patterns in Small Cell Carcinoma of the Cervix: Insights from a Multidisciplinary Survey. Current Oncology. 2024; 31(5):2610-2619. https://doi.org/10.3390/curroncol31050196
Chicago/Turabian StyleFan, Kevin Yijun, Rania Chehade, Andrew Yuanbo Wang, Anjali Sachdeva, Helen J. MacKay, and Amandeep S. Taggar. 2024. "Pan-Canadian Analysis of Practice Patterns in Small Cell Carcinoma of the Cervix: Insights from a Multidisciplinary Survey" Current Oncology 31, no. 5: 2610-2619. https://doi.org/10.3390/curroncol31050196